XML 67 R92.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 28, 2020
Dec. 31, 2019
Sep. 28, 2019
Jun. 29, 2019
Mar. 30, 2019
Sep. 29, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2015
Feb. 05, 2020
Equity [Line Items]                            
Dividends declared per share   $ 0.08 $ 0.08 $ 0.07 $ 0.07 $ 0.07 $ 0.07 $ 0.07 $ 0.07   $ 0.07      
Dividends, Common Stock, Cash                 $ 9,900 $ 40,784 $ 39,722 $ 9,896    
Common Stock, Dividends, Per Share, Declared                   $ 0.30 $ 0.28 $ 0.07    
Stock Repurchase Program, Authorized Amount                     $ 100,000      
Additional stock repurchase authorization                     250,000      
Stock Repurchased and Retired During Period, Value                   $ 74,787 179,315 $ 28,000    
Shares absorbed into plan                         5,700  
Term of plan, in years                   10 years        
Weighted average remaining contractual term option outstanding                   4 years        
Weighted average remaining contractual term option exercisable                   3 years        
Total pre-tax intrinsic value of stock options exercised                   $ 3,200 $ 16,700      
Total pre-tax intrinsic value based on the closing stock price   $ 50.09               $ 50.09        
Intrinsic value of stock options outstanding   $ 45,200               $ 45,200        
Intrinsic value of stock options exercisable   $ 27,100               $ 27,100        
Share-based payment awards in the form of stock option awards                   293 296 335    
Contractual term of stock options (in years)                   7 years        
Shares available for future grants   8,200             8,800 8,200 8,700 8,800    
Weighted average remaining contractual term for unvested restricted shares, in years                   2 years 1 year 10 months 24 days      
performance shares granted                   100 200 100    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition                   2 years 6 months        
Maximum                            
Equity [Line Items]                            
Vesting period, in years                   4 years        
Unvested Stock Options                            
Equity [Line Items]                            
Total compensation cost not yet recognized   $ 3,700               $ 3,700        
Performance Stock                            
Equity [Line Items]                            
Total compensation cost not yet recognized   2,600               2,600        
Restricted Stock                            
Equity [Line Items]                            
Total compensation cost not yet recognized   $ 22,100               $ 22,100        
Employee Stock Purchase Plan                            
Equity [Line Items]                            
Percentage of employee contribution from compensation                   10.00%        
Rate of discount from the fair market value                   15.00%        
Shares available for future grants   1,700               1,700        
Shares purchase by employees                   200 200 200    
Weighted-average price per share paid by the employees   $ 28.67             $ 16.92 $ 28.67 $ 24.86 $ 16.92    
Subsequent Event [Member]                            
Equity [Line Items]                            
Common Stock, Dividends, Per Share, Declared $ 0.08                          
Stock Repurchase Program, Authorized Amount                           $ 125,000